Filing Details

Accession Number:
0001179110-20-008797
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-07 16:48:40
Reporting Period:
2020-08-05
Accepted Time:
2020-08-07 16:48:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1256088 Georges Gemayel C/O Momenta Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-05 10,000 $14.84 24,090 No 4 M Direct
Common Stock Disposition 2020-08-05 10,000 $33.00 14,090 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-08-05 10,000 $0.00 10,000 $14.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2018-01-01 2026-01-01 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 28, 2020